Skip to content

Oral versus vaginal administration of misoprostol for induction of labor in women with pre labour rupture of membranes. Results of a randomized controlled trial

Oral versus vaginal administration of misoprostol for induction of labor in women with pre labour rupture of membranes. Results of a randomized controlled trial - Oral versus vaginal misoprostol for PROM

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039212
Enrollment
51
Registered
2021-01-20
Start date
2019-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature rupture of membranes at term

Interventions

25 mcg of misoprostol 2- hourly, orally 25mcg misoprostol vaginally, 3-hourly

Sponsors

JNMC
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: RROM

Exclusion criteria

Exclusion criteria: CD 4 BS 6

Design outcomes

Primary

MeasureTime frame
Primary outcome measure was to compare the effectiveness of orally administered misoprostol, with vaginally administered misoprostol for induction of labor in PROM cases.

Secondary

MeasureTime frame
Secondary outcomes were evaluation of mean interval between induction and active labor and the Induction to delivery interval.

Countries

Asia(except Japan)

Contacts

Public ContactRahul Bhargava

Rama Medical College Hapur

brahul2371@gmail.com9999055223

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026